WAT
Waters Corporation
Diagnostics & Research · Healthcare · United States
413.51
close · 2026-08-13
value
35
cheaper than peers35
quality
81
stronger fundamentals81
ranked against
Diagnostics & Research
value
quality
28 peers
Value inputs
| measure | company | vs peers |
| price to book | 2.65× | 79 |
| forward P/E | 24.97× | 45 |
| price to sales | 10.31× | 24 |
| EV to EBITDA | 36.95× | 15 |
4 of 12 measures available
Quality inputs
| measure | company | vs peers |
| revenue growth | 91.4% | 98 |
| debt to equity | 36.6% | 63 |
| return on equity | 5.2% | 52 |
| operating margin | 2.8% | 50 |
4 of 4 measures available
Facts
| market cap | $41B |
| free cash flow | -$502.4M |
| employees | 16,000 |
| first trade | 1995-11-17 |
| next earnings | 2026-08-04 |
| fundamentals updated | 2026-08-04 |